An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers
Clinical trial NCT03363776 · TERMINATED
Trial details
- NCT number
- NCT03363776
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2019-11-22
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.